Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 247 shares at $6.91 ($2K) on 2020-05-27, disclosed to the SEC on 2020-05-28.
Open-market sale of $2k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |